These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34766510)
1. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs. Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510 [No Abstract] [Full Text] [Related]
2. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment. Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950 [TBL] [Abstract][Full Text] [Related]
3. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521 [TBL] [Abstract][Full Text] [Related]
4. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839 [TBL] [Abstract][Full Text] [Related]
5. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacist involvement in expanding naloxone distribution in a veteran population. McQuillan A Am J Health Syst Pharm; 2022 Mar; 79(6):472-476. PubMed ID: 34755851 [TBL] [Abstract][Full Text] [Related]
7. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event. Alexander M; Hooker J; Stratton M; Huh M; Houck K J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200 [TBL] [Abstract][Full Text] [Related]
8. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA; J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502 [TBL] [Abstract][Full Text] [Related]
9. Reprint of: Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event. Alexander M; Hooker J; Stratton M; Huh M; Houck K J Am Pharm Assoc (2003); 2024; 64(4S):102168. PubMed ID: 39127946 [TBL] [Abstract][Full Text] [Related]
10. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643 [TBL] [Abstract][Full Text] [Related]
11. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center. Pauly JB; Vartan CM; Brooks AT Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760 [TBL] [Abstract][Full Text] [Related]
12. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks. Bounthavong M; Shayegani R; Manning JM; Marin J; Spoutz P; Hoffman JD; Harvey MA; Himstreet JE; Kay CL; Freeman BA; Almeida A; Christopher MLD Int J Med Inform; 2022 May; 161():104712. PubMed ID: 35196600 [TBL] [Abstract][Full Text] [Related]
13. Telephone-based opioid overdose education and naloxone distribution (OEND) pharmacy consult clinic. Szydlowski EM; Caruana SS Subst Abus; 2018; 39(2):145-151. PubMed ID: 31032747 [TBL] [Abstract][Full Text] [Related]
14. Naloxone Academic Detailing: Role of Community Outreach Teaching. Abd-Elsayed A; Albert CA; Fischer M; Anderson B Curr Pain Headache Rep; 2018 Aug; 22(11):72. PubMed ID: 30151695 [TBL] [Abstract][Full Text] [Related]
15. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location. Kohan LR; Elmofty D; Pena I; Liao C J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425 [TBL] [Abstract][Full Text] [Related]
16. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial. Lambdin BH; Bluthenthal RN; Garner BR; Wenger LD; Browne EN; Morris T; Ongais L; Megerian CE; Kral AH Implement Sci; 2024 Feb; 19(1):22. PubMed ID: 38419058 [TBL] [Abstract][Full Text] [Related]
17. Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs. Bounthavong M; Lau MK; Kay CL; Wells DL; Popish SJ; Harvey MA; Himstreet JE; Grana A; Freeman BA; Morillo CM; Christopher MLD Pain Med; 2021 Jun; 22(6):1426-1434. PubMed ID: 33749779 [TBL] [Abstract][Full Text] [Related]
18. Naloxone Prescribing in an Academic Emergency Department: Provider Practices and Attitudes. Hernandez-Meier J; Li D; Zosel A WMJ; 2023 Mar; 122(1):20-25. PubMed ID: 36940117 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients. Jakubowski A; Pappas A; Isaacsohn L; Castillo F; Masyukova M; Silvera R; Holaday L; Rausch E; Farooq S; Veltri KT; Cunningham CO; Bachhuber MA Subst Abus; 2019; 40(1):61-65. PubMed ID: 30475162 [No Abstract] [Full Text] [Related]
20. Legal requirements and recommendations to prescribe naloxone. Haffajee RL; Cherney S; Smart R Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]